These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15046208)

  • 1. In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line.
    Morgan C; Alazawi W; Sirieix P; Freeman T; Coleman N; Fitzgerald R
    Am J Gastroenterol; 2004 Feb; 99(2):218-24. PubMed ID: 15046208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
    Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
    BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.
    Souza RF; Shewmake K; Terada LS; Spechler SJ
    Gastroenterology; 2002 Feb; 122(2):299-307. PubMed ID: 11832445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
    Souza RF; Shewmake K; Pearson S; Sarosi GA; Feagins LA; Ramirez RD; Terada LS; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G743-8. PubMed ID: 15231484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro.
    Tselepis C; Morris CD; Wakelin D; Hardy R; Perry I; Luong QT; Harper E; Harrison R; Attwood SE; Jankowski JA
    Gut; 2003 Feb; 52(2):174-80. PubMed ID: 12524396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
    Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
    Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions.
    Phipps SM; Garry CE; Kamal S; Johnson JD; Gilmer J; Long A; Kelleher D; Duggan SP
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):601-622. PubMed ID: 32416156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.
    Smith CM; Watson DI; Leong MP; Mayne GC; Michael MZ; Wijnhoven BP; Hussey DJ
    World J Gastroenterol; 2011 Feb; 17(8):1036-44. PubMed ID: 21448356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets for treatment of Barrett's esophagus.
    Feagins LA; Souza RF
    Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma.
    Wang XW; Gao HJ; Fang DC
    J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy.
    Abdel-Latif MM; O'Riordan J; Windle HJ; Carton E; Ravi N; Kelleher D; Reynolds JV
    Ann Surg; 2004 Apr; 239(4):491-500. PubMed ID: 15024310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger.
    Sarosi GA; Jaiswal K; Herndon E; Lopez-Guzman C; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G991-7. PubMed ID: 16081761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.
    Beilstein M; Silberg D
    Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma.
    Moore JH; Lesser EJ; Erdody DH; Natale RB; Orringer MB; Beer DG
    Int J Cancer; 1994 Feb; 56(4):487-93. PubMed ID: 7906678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.
    Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM
    Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK and PI3K inhibition reduces proliferation of Barrett's adenocarcinoma in vitro.
    Vona-Davis L; Frankenberry K; Cunningham C; Riggs DR; Jackson BJ; Szwerc MF; McFadden DW
    J Surg Res; 2005 Jul; 127(1):53-8. PubMed ID: 15964304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.